No abstract available
MeSH terms
-
Alanine / analogs & derivatives
-
Alanine / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use
-
Benzamides / therapeutic use
-
Cancer Vaccines
-
Clinical Trials as Topic*
-
Colorectal Neoplasms / mortality
-
Colorectal Neoplasms / pathology
-
Colorectal Neoplasms / therapy*
-
Doxorubicin / chemistry
-
Drug Combinations
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hyperthermia, Induced
-
Lapatinib
-
Liposomes / chemistry
-
Niacinamide / analogs & derivatives
-
Niacinamide / therapeutic use
-
Phenylurea Compounds / therapeutic use
-
Protein Kinase Inhibitors / therapeutic use
-
Pyridines / therapeutic use
-
Pyrrolidines
-
Quinazolines / therapeutic use
-
Ramucirumab
-
Sorafenib
-
Thymine
-
Topoisomerase I Inhibitors / therapeutic use
-
Triazines / therapeutic use
-
Trifluridine / therapeutic use
-
Uracil / analogs & derivatives
-
Uracil / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Benzamides
-
Cancer Vaccines
-
Drug Combinations
-
FANG vaccine
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Liposomes
-
Phenylurea Compounds
-
Protein Kinase Inhibitors
-
Pyridines
-
Pyrrolidines
-
Quinazolines
-
Topoisomerase I Inhibitors
-
Triazines
-
trifluridine tipiracil drug combination
-
Lapatinib
-
entinostat
-
Niacinamide
-
Uracil
-
Doxorubicin
-
Sorafenib
-
brivanib
-
Alanine
-
Thymine
-
Trifluridine